Likewise, adenoid cystic carcinoma (ACC) tumor xenografts with activating Notch1 mutations responded to Notch inhibition, whereas the tumors without Notch1 mutation and low levels of NICD1 were resistant [201]. This evidence concerns the gene NOTCH1 and adenoid cystic carcinoma.